Genome-wide association studies: inherent limitations and future challenges

Genome-wide association studies (GWAS) have achieved great success in identifying genetic variants related to complex human diseases such as cancer and have provided valuable insights into their genetic architecture. Recently, GWAS is quite the fashion in China. However, there are issues related to its nature. Enormous work needs to be done in the post-GWAS era. Deep sequencing followed by functional studies will be needed to elucidate the underpinning biological mechanisms and further translate GWAS findings into medical practice. Along with pharmacogenomics, the success of GWAS in identifying genetic risk factors and genetic differences in drug response has been gradually enabling personalized medicine. In this article, we used hepatocellular carcinoma (HCC) as an example to demonstrate some of the inherent limitations and summarized future challenges of GWAS.

[1]  Wen Tan,et al.  A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1 , 2011, Nature Genetics.

[2]  Rajagopal N. Aravalli,et al.  Molecular mechanisms of hepatocellular carcinoma , 2008, Hepatology.

[3]  H. Hakonarson,et al.  Analysing biological pathways in genome-wide association studies , 2010, Nature Reviews Genetics.

[4]  Hong-wei Zhang,et al.  Association of novel mutations and heplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma , 2010, Frontiers of medicine in China.

[5]  K. Chayama,et al.  Hepatocellular carcinoma: Towards personalized medicine , 2012, Cancer science.

[6]  E. Rondeau,et al.  Warning: Genome‐wide association studies can be misleading. An example in hepatology , 2011, Hepatology.

[7]  Yusuke Nakamura,et al.  Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers , 2011, Nature Genetics.

[8]  P. Sham,et al.  Genome-Wide Association Study of Hepatocellular Carcinoma in Southern Chinese Patients with Chronic Hepatitis B Virus Infection , 2011, PloS one.

[9]  Wen Tan,et al.  Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations , 2011, Nature Genetics.

[10]  G. Dore,et al.  Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden , 2009, Journal of viral hepatitis.

[11]  Yusuke Nakamura,et al.  Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma , 2011, Nature Genetics.

[12]  Wen Tan,et al.  A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese , 2011, Nature Genetics.

[13]  Fuchu He,et al.  Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers , 2010, Nature Genetics.

[14]  Hong-Yang Wang,et al.  Dysregulation of β-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas , 2010, Frontiers of medicine in China.

[15]  M. Beckmann,et al.  Genome-Wide Association Study Identifies a Possible Susceptibility Locus for Endometrial Cancer , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[16]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[17]  Paolo Vineis,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[18]  G. Cao,et al.  Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma , 2010, Journal of Gastroenterology.

[19]  Hong-wei Zhang,et al.  Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. , 2011, World journal of gastroenterology.

[20]  Bin Liu,et al.  Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 , 2010, Nature Genetics.

[21]  K. Buetow,et al.  Pathways of Distinction Analysis: A New Technique for Multi–SNP Analysis of GWAS Data , 2010, PLoS genetics.

[22]  E. Liu,et al.  A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci , 2010, Nature Genetics.

[23]  Y. Pawitan,et al.  The pursuit of genome-wide association studies: where are we now? , 2010, Journal of Human Genetics.

[24]  N. Hu,et al.  A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma , 2010, Nature Genetics.

[25]  Bin Liu,et al.  : Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and , 2010 .

[26]  G. Mills,et al.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.

[27]  Sharon I. Greenblum,et al.  Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma , 2010, Hepatology.

[28]  G. Cao,et al.  Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis , 2009, Journal of the National Cancer Institute.

[29]  Stephen J. Chanock,et al.  Current status of genome-wide association studies in cancer , 2011, Human Genetics.

[30]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[31]  G. Cao,et al.  Association Between the Various Mutations in Viral Core Promoter Region to Different Stages of Hepatitis B, Ranging of Asymptomatic Carrier State to Hepatocellular Carcinoma , 2011, The American Journal of Gastroenterology.

[32]  Hongbing Shen,et al.  Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations , 2011, Nature Genetics.